Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin

scientific article published on December 2013

Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1039/C3NR04268E
P698PubMed publication ID24150593

P50authorVeronica MoreaQ29048223
Patrizio GiacominiQ38642656
Pierpaolo CeciQ43021303
Carlo LeonettiQ45362876
Elisabetta FalvoQ56285704
Elisa TremanteQ56285705
Rocco FraioliQ62686148
P2093author name stringAlberto Boffi
Carlotta Zamparelli
P2860cites workMagnetoferritin nanoparticles for targeting and visualizing tumour tissuesQ29400779
Protein-based nanocarriers as promising drug and gene delivery systems.Q30416469
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1.Q33734849
CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.Q33784789
Effective encapsulation of a new cationic gadolinium chelate into apoferritin and its evaluation as an MRI contrast agentQ33824447
Chimeric ferritin nanocages for multiple function loading and multimodal imagingQ34565032
RGD-modified apoferritin nanoparticles for efficient drug delivery to tumorsQ34652361
Thioaptamer conjugated liposomes for tumor vasculature targetingQ35640211
Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?Q37029367
Protein-based nanomedicine platforms for drug deliveryQ37538630
The ferritin superfamily: Supramolecular templates for materials synthesisQ37660707
Superparamagnetic nanoparticles as targeted probes for diagnostic and therapeutic applicationsQ37744631
Reactions inside nanoscale protein cagesQ37860963
The beating heart of melanomas: a minor subset of cancer cells sustains tumor growthQ37864489
CSPG4, a potential therapeutic target, facilitates malignant progression of melanomaQ37946449
Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier designQ37949042
Melanoma molecular classes and prognosis in the postgenomic era.Q38007231
The detection and quantitation of protein oligomerizationQ38040717
Human ferritin for tumor detection and therapy.Q38100772
Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targetingQ39343906
Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatformQ39357148
Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cellsQ39443775
Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritinQ39841874
Electrostatic assembly of binary nanoparticle superlattices using protein cagesQ57183943
Magnetic nanoparticles--templated assembly of protein subunits: a new platform for carbohydrate-based MRI nanoprobesQ57185193
Magnetic Resonance Visualization of Tumor Angiogenesis by Targeting Neural Cell Adhesion Molecules with the Highly Sensitive Gadolinium-Loaded Apoferritin ProbeQ58831586
Hierarchical Self-Assembly and Optical Disassembly for Controlled Switching of Magnetoferritin Nanoparticle MagnetismQ61646482
P433issue24
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
cisplatinQ412415
antibodyQ79460
P304page(s)12278-12285
P577publication date2013-12-01
P1433published inNanoscaleQ3335756
P1476titleAntibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin
P478volume5

Reverse relations

cites work (P2860)
Q59356102Bioengineering Strategies for Protein-Based Nanoparticles
Q50918966CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL.
Q27704043Cisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic study
Q48923575Conversion of the Native 24-mer Ferritin Nanocage into Its Non-Native 16-mer Analogue by Insertion of Extra Amino Acid Residues
Q51326343Engineering protein interfaces yields ferritin disassembly and reassembly under benign experimental conditions.
Q38776237Ferritin cage for encapsulation and delivery of bioactive nutrients: From structure, property to applications.
Q88011808Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting
Q87957089Functional ferritin nanoparticles for biomedical applications
Q38664186Functionalized protein nanocages as a platform of targeted therapy and immunodetection
Q34383748H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.
Q48165104Humanized archaeal ferritin as a tool for cell targeted delivery.
Q26798379Nanoparticle-mediated drug delivery for treating melanoma
Q36978587Nanoparticles and nanofibers for topical drug delivery
Q41007441Platinum-conjugated antibodies for application in mass cytometry
Q45858764Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin
Q116166336Role of ARP2/3 Complex-Driven Actin Polymerization in RSV Infection
Q38254088Synthetic and bioinspired cage nanoparticles for drug delivery
Q36078281Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor
Q39325532The regulatory mechanisms of NG2/CSPG4 expression
Q41183225Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.
Q36693096Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles
Q60921652Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells
Q50905102X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage.

Search more.